You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

NIVL(MNT)

Cancer Type: Skin, Melanoma      Intent: Palliative
Regimen Category: Evidence-informed
Funding:
New Drug Funding Program
    Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

You might also be interested in